Submitted by Anonymous (not verified) on 4 November 2025 - 15:44
Human medicines European public assessment report (EPAR): Finlee, dabrafenib, Date of authorisation: 15/11/2023, Revision: 7, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Finlee, dabrafenib, Date of authorisation: 15/11/2023, Revision: 7, Status: Authorised